United States Sexually Transmitted Diseases Diagnostics Market Report 2017

October 2017 | 106 pages | ID: U378B36ABF1WEN
QYResearch

Abstracts

In this report, the United States Sexually Transmitted Diseases Diagnostics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Sexually Transmitted Diseases Diagnostics in these regions, from 2012 to 2022 (forecast).

United States Sexually Transmitted Diseases Diagnostics market competition by top manufacturers/players, with Sexually Transmitted Diseases Diagnostics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Roche Holdings AG
• Abbott Laboratories
• Becton Dickinson and Company
• Hologic Inc
• Danaher Corporation
• Affymetrix
• bioMerieux
• Cepheid Inc
• Alere Inc
• DiaSorin
• Orasure

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Chlamydia Testing
• Syphilis Testing
• Gonorrhea Testing
• Herpes Simplex Virus Testing
• Human Papilloma Virus Testing
• Human Immunodeficiency Virus Testing
• Chancroid Testing

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Sexually Transmitted Diseases Diagnostics for each application, including

• Hospital
• Cinic
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Sexually Transmitted Diseases Diagnostics Market Report 2017

1 SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS OVERVIEW

1.1 Product Overview and Scope of Sexually Transmitted Diseases Diagnostics
1.2 Classification of Sexually Transmitted Diseases Diagnostics by Product Category
  1.2.1 United States Sexually Transmitted Diseases Diagnostics Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Sexually Transmitted Diseases Diagnostics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Chlamydia Testing
  1.2.4 Syphilis Testing
  1.2.5 Gonorrhea Testing
  1.2.6 Herpes Simplex Virus Testing
  1.2.7 Human Papilloma Virus Testing
  1.2.8 Human Immunodeficiency Virus Testing
  1.2.9 Chancroid Testing
1.3 United States Sexually Transmitted Diseases Diagnostics Market by Application/End Users
  1.3.1 United States Sexually Transmitted Diseases Diagnostics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Cinic
  1.3.4 Other
1.4 United States Sexually Transmitted Diseases Diagnostics Market by Region
  1.4.1 United States Sexually Transmitted Diseases Diagnostics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Sexually Transmitted Diseases Diagnostics Status and Prospect (2012-2022)
  1.4.3 Southwest Sexually Transmitted Diseases Diagnostics Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Sexually Transmitted Diseases Diagnostics Status and Prospect (2012-2022)
  1.4.5 New England Sexually Transmitted Diseases Diagnostics Status and Prospect (2012-2022)
  1.4.6 The South Sexually Transmitted Diseases Diagnostics Status and Prospect (2012-2022)
  1.4.7 The Midwest Sexually Transmitted Diseases Diagnostics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Sexually Transmitted Diseases Diagnostics (2012-2022)
  1.5.1 United States Sexually Transmitted Diseases Diagnostics Sales and Growth Rate (2012-2022)
  1.5.2 United States Sexually Transmitted Diseases Diagnostics Revenue and Growth Rate (2012-2022)

2 UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Sexually Transmitted Diseases Diagnostics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Sexually Transmitted Diseases Diagnostics Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Sexually Transmitted Diseases Diagnostics Average Price by Players/Suppliers (2012-2017)
2.4 United States Sexually Transmitted Diseases Diagnostics Market Competitive Situation and Trends
  2.4.1 United States Sexually Transmitted Diseases Diagnostics Market Concentration Rate
  2.4.2 United States Sexually Transmitted Diseases Diagnostics Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Sexually Transmitted Diseases Diagnostics Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Sexually Transmitted Diseases Diagnostics Sales and Market Share by Region (2012-2017)
3.2 United States Sexually Transmitted Diseases Diagnostics Revenue and Market Share by Region (2012-2017)
3.3 United States Sexually Transmitted Diseases Diagnostics Price by Region (2012-2017)

4 UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Sexually Transmitted Diseases Diagnostics Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Sexually Transmitted Diseases Diagnostics Revenue and Market Share by Type (2012-2017)
4.3 United States Sexually Transmitted Diseases Diagnostics Price by Type (2012-2017)
4.4 United States Sexually Transmitted Diseases Diagnostics Sales Growth Rate by Type (2012-2017)

5 UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Sexually Transmitted Diseases Diagnostics Sales and Market Share by Application (2012-2017)
5.2 United States Sexually Transmitted Diseases Diagnostics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Roche Holdings AG
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Sexually Transmitted Diseases Diagnostics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Roche Holdings AG Sexually Transmitted Diseases Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Abbott Laboratories
  6.2.2 Sexually Transmitted Diseases Diagnostics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Abbott Laboratories Sexually Transmitted Diseases Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Becton Dickinson and Company
  6.3.2 Sexually Transmitted Diseases Diagnostics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Becton Dickinson and Company Sexually Transmitted Diseases Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Hologic Inc
  6.4.2 Sexually Transmitted Diseases Diagnostics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Hologic Inc Sexually Transmitted Diseases Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Danaher Corporation
  6.5.2 Sexually Transmitted Diseases Diagnostics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Danaher Corporation Sexually Transmitted Diseases Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Affymetrix
  6.6.2 Sexually Transmitted Diseases Diagnostics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Affymetrix Sexually Transmitted Diseases Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 bioMerieux
  6.7.2 Sexually Transmitted Diseases Diagnostics Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 bioMerieux Sexually Transmitted Diseases Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Cepheid Inc
  6.8.2 Sexually Transmitted Diseases Diagnostics Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Cepheid Inc Sexually Transmitted Diseases Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Alere Inc
  6.9.2 Sexually Transmitted Diseases Diagnostics Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Alere Inc Sexually Transmitted Diseases Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 DiaSorin
  6.10.2 Sexually Transmitted Diseases Diagnostics Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 DiaSorin Sexually Transmitted Diseases Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Orasure

7 SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MANUFACTURING COST ANALYSIS

7.1 Sexually Transmitted Diseases Diagnostics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Sexually Transmitted Diseases Diagnostics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Sexually Transmitted Diseases Diagnostics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Sexually Transmitted Diseases Diagnostics Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Sexually Transmitted Diseases Diagnostics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Sexually Transmitted Diseases Diagnostics Sales Volume Forecast by Type (2017-2022)
11.3 United States Sexually Transmitted Diseases Diagnostics Sales Volume Forecast by Application (2017-2022)
11.4 United States Sexually Transmitted Diseases Diagnostics Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Sexually Transmitted Diseases Diagnostics
Figure United States Sexually Transmitted Diseases Diagnostics Market Size (K Pcs) by Type (2012-2022)
Figure United States Sexually Transmitted Diseases Diagnostics Sales Volume Market Share by Type (Product Category) in 2016
Figure Chlamydia Testing Product Picture
Figure Syphilis Testing Product Picture
Figure Gonorrhea Testing Product Picture
Figure Herpes Simplex Virus Testing Product Picture
Figure Human Papilloma Virus Testing Product Picture
Figure Human Immunodeficiency Virus Testing Product Picture
Figure Chancroid Testing Product Picture
Figure United States Sexually Transmitted Diseases Diagnostics Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Sexually Transmitted Diseases Diagnostics by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Cinic Examples
Table Key Downstream Customer in Cinic
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Sexually Transmitted Diseases Diagnostics Market Size (Million USD) by Region (2012-2022)
Figure The West Sexually Transmitted Diseases Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Sexually Transmitted Diseases Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Sexually Transmitted Diseases Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Sexually Transmitted Diseases Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Sexually Transmitted Diseases Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Sexually Transmitted Diseases Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Sexually Transmitted Diseases Diagnostics Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Sexually Transmitted Diseases Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Sexually Transmitted Diseases Diagnostics Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Sexually Transmitted Diseases Diagnostics Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Sexually Transmitted Diseases Diagnostics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Sexually Transmitted Diseases Diagnostics Sales Share by Players/Suppliers
Figure 2017 United States Sexually Transmitted Diseases Diagnostics Sales Share by Players/Suppliers
Figure United States Sexually Transmitted Diseases Diagnostics Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Sexually Transmitted Diseases Diagnostics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Sexually Transmitted Diseases Diagnostics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Sexually Transmitted Diseases Diagnostics Revenue Share by Players/Suppliers
Figure 2017 United States Sexually Transmitted Diseases Diagnostics Revenue Share by Players/Suppliers
Table United States Market Sexually Transmitted Diseases Diagnostics Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Sexually Transmitted Diseases Diagnostics Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Sexually Transmitted Diseases Diagnostics Market Share of Top 3 Players/Suppliers
Figure United States Sexually Transmitted Diseases Diagnostics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Sexually Transmitted Diseases Diagnostics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Sexually Transmitted Diseases Diagnostics Product Category
Table United States Sexually Transmitted Diseases Diagnostics Sales (K Pcs) by Region (2012-2017)
Table United States Sexually Transmitted Diseases Diagnostics Sales Share by Region (2012-2017)
Figure United States Sexually Transmitted Diseases Diagnostics Sales Share by Region (2012-2017)
Figure United States Sexually Transmitted Diseases Diagnostics Sales Market Share by Region in 2016
Table United States Sexually Transmitted Diseases Diagnostics Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Sexually Transmitted Diseases Diagnostics Revenue Share by Region (2012-2017)
Figure United States Sexually Transmitted Diseases Diagnostics Revenue Market Share by Region (2012-2017)
Figure United States Sexually Transmitted Diseases Diagnostics Revenue Market Share by Region in 2016
Table United States Sexually Transmitted Diseases Diagnostics Price (USD/Pcs) by Region (2012-2017)
Table United States Sexually Transmitted Diseases Diagnostics Sales (K Pcs) by Type (2012-2017)
Table United States Sexually Transmitted Diseases Diagnostics Sales Share by Type (2012-2017)
Figure United States Sexually Transmitted Diseases Diagnostics Sales Share by Type (2012-2017)
Figure United States Sexually Transmitted Diseases Diagnostics Sales Market Share by Type in 2016
Table United States Sexually Transmitted Diseases Diagnostics Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Sexually Transmitted Diseases Diagnostics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Sexually Transmitted Diseases Diagnostics by Type (2012-2017)
Figure Revenue Market Share of Sexually Transmitted Diseases Diagnostics by Type in 2016
Table United States Sexually Transmitted Diseases Diagnostics Price (USD/Pcs) by Types (2012-2017)
Figure United States Sexually Transmitted Diseases Diagnostics Sales Growth Rate by Type (2012-2017)
Table United States Sexually Transmitted Diseases Diagnostics Sales (K Pcs) by Application (2012-2017)
Table United States Sexually Transmitted Diseases Diagnostics Sales Market Share by Application (2012-2017)
Figure United States Sexually Transmitted Diseases Diagnostics Sales Market Share by Application (2012-2017)
Figure United States Sexually Transmitted Diseases Diagnostics Sales Market Share by Application in 2016
Table United States Sexually Transmitted Diseases Diagnostics Sales Growth Rate by Application (2012-2017)
Figure United States Sexually Transmitted Diseases Diagnostics Sales Growth Rate by Application (2012-2017)
Table Roche Holdings AG Basic Information List
Table Roche Holdings AG Sexually Transmitted Diseases Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Roche Holdings AG Sexually Transmitted Diseases Diagnostics Sales Growth Rate (2012-2017)
Figure Roche Holdings AG Sexually Transmitted Diseases Diagnostics Sales Market Share in United States (2012-2017)
Figure Roche Holdings AG Sexually Transmitted Diseases Diagnostics Revenue Market Share in United States (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Sexually Transmitted Diseases Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Laboratories Sexually Transmitted Diseases Diagnostics Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Sexually Transmitted Diseases Diagnostics Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories Sexually Transmitted Diseases Diagnostics Revenue Market Share in United States (2012-2017)
Table Becton Dickinson and Company Basic Information List
Table Becton Dickinson and Company Sexually Transmitted Diseases Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Becton Dickinson and Company Sexually Transmitted Diseases Diagnostics Sales Growth Rate (2012-2017)
Figure Becton Dickinson and Company Sexually Transmitted Diseases Diagnostics Sales Market Share in United States (2012-2017)
Figure Becton Dickinson and Company Sexually Transmitted Diseases Diagnostics Revenue Market Share in United States (2012-2017)
Table Hologic Inc Basic Information List
Table Hologic Inc Sexually Transmitted Diseases Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Hologic Inc Sexually Transmitted Diseases Diagnostics Sales Growth Rate (2012-2017)
Figure Hologic Inc Sexually Transmitted Diseases Diagnostics Sales Market Share in United States (2012-2017)
Figure Hologic Inc Sexually Transmitted Diseases Diagnostics Revenue Market Share in United States (2012-2017)
Table Danaher Corporation Basic Information List
Table Danaher Corporation Sexually Transmitted Diseases Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Danaher Corporation Sexually Transmitted Diseases Diagnostics Sales Growth Rate (2012-2017)
Figure Danaher Corporation Sexually Transmitted Diseases Diagnostics Sales Market Share in United States (2012-2017)
Figure Danaher Corporation Sexually Transmitted Diseases Diagnostics Revenue Market Share in United States (2012-2017)
Table Affymetrix Basic Information List
Table Affymetrix Sexually Transmitted Diseases Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Affymetrix Sexually Transmitted Diseases Diagnostics Sales Growth Rate (2012-2017)
Figure Affymetrix Sexually Transmitted Diseases Diagnostics Sales Market Share in United States (2012-2017)
Figure Affymetrix Sexually Transmitted Diseases Diagnostics Revenue Market Share in United States (2012-2017)
Table bioMerieux Basic Information List
Table bioMerieux Sexually Transmitted Diseases Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure bioMerieux Sexually Transmitted Diseases Diagnostics Sales Growth Rate (2012-2017)
Figure bioMerieux Sexually Transmitted Diseases Diagnostics Sales Market Share in United States (2012-2017)
Figure bioMerieux Sexually Transmitted Diseases Diagnostics Revenue Market Share in United States (2012-2017)
Table Cepheid Inc Basic Information List
Table Cepheid Inc Sexually Transmitted Diseases Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cepheid Inc Sexually Transmitted Diseases Diagnostics Sales Growth Rate (2012-2017)
Figure Cepheid Inc Sexually Transmitted Diseases Diagnostics Sales Market Share in United States (2012-2017)
Figure Cepheid Inc Sexually Transmitted Diseases Diagnostics Revenue Market Share in United States (2012-2017)
Table Alere Inc Basic Information List
Table Alere Inc Sexually Transmitted Diseases Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Alere Inc Sexually Transmitted Diseases Diagnostics Sales Growth Rate (2012-2017)
Figure Alere Inc Sexually Transmitted Diseases Diagnostics Sales Market Share in United States (2012-2017)
Figure Alere Inc Sexually Transmitted Diseases Diagnostics Revenue Market Share in United States (2012-2017)
Table DiaSorin Basic Information List
Table DiaSorin Sexually Transmitted Diseases Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure DiaSorin Sexually Transmitted Diseases Diagnostics Sales Growth Rate (2012-2017)
Figure DiaSorin Sexually Transmitted Diseases Diagnostics Sales Market Share in United States (2012-2017)
Figure DiaSorin Sexually Transmitted Diseases Diagnostics Revenue Market Share in United States (2012-2017)
Table Orasure Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sexually Transmitted Diseases Diagnostics
Figure Manufacturing Process Analysis of Sexually Transmitted Diseases Diagnostics
Figure Sexually Transmitted Diseases Diagnostics Industrial Chain Analysis
Table Raw Materials Sources of Sexually Transmitted Diseases Diagnostics Major Players/Suppliers in 2016
Table Major Buyers of Sexually Transmitted Diseases Diagnostics
Table Distributors/Traders List
Figure United States Sexually Transmitted Diseases Diagnostics Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Sexually Transmitted Diseases Diagnostics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Sexually Transmitted Diseases Diagnostics Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Sexually Transmitted Diseases Diagnostics Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Sexually Transmitted Diseases Diagnostics Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Sexually Transmitted Diseases Diagnostics Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Sexually Transmitted Diseases Diagnostics Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Sexually Transmitted Diseases Diagnostics Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Sexually Transmitted Diseases Diagnostics Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Sexually Transmitted Diseases Diagnostics Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Sexually Transmitted Diseases Diagnostics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Sexually Transmitted Diseases Diagnostics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Sexually Transmitted Diseases Diagnostics Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources